Loading clinical trials...
Loading clinical trials...
Modulation of Inflammatory Makers by the Supplementation of n7FA for 3 wk, Randomized Placebo Controlled Crossover Study
Conditions
Interventions
omega 7
Placebo
Locations
1
United States
Bastyr University Clinical Research Center
Kenmore, Washington, United States
Start Date
September 1, 2017
Primary Completion Date
June 30, 2019
Completion Date
October 1, 2019
Last Updated
October 15, 2019
NCT06704061
NCT05701982
NCT04441619
NCT07347028
NCT07245303
NCT06398847
Lead Sponsor
Bastyr University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions